These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 6958210)

  • 1. Systemic lupus erythematosus during penicillamine therapy for rheumatoid arthritis.
    Chalmers A; Thompson D; Stein HE; Reid G; Patterson AC
    Ann Intern Med; 1982 Nov; 97(5):659-63. PubMed ID: 6958210
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Penicillamine-induced lupus-like reaction in rheumatoid arthritis and vasculitis.
    Thorvaldsen J
    Dermatologica; 1981; 162(4):277-80. PubMed ID: 6455314
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [D-penicillamine induced lupus during the treatment of rheumatoid arthritis. Report of 2 cases and systematic immunologic study during the treatment].
    Crouzet J; Camus JP; Leca AP; Guillien P; Lièvre JA
    Ann Med Interne (Paris); 1974 Jan; 125(1):71-9. PubMed ID: 4136184
    [No Abstract]   [Full Text] [Related]  

  • 4. D-penicillamine and immune complex deposition.
    Kirby JD; Dieppe PA; Huskisson EC; Smith B
    Ann Rheum Dis; 1979 Aug; 38(4):344-6. PubMed ID: 159020
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combination therapy for rheumatoid arthritis and drug-induced systemic lupus erythematosus.
    Borg AA; Davis MJ; Dawes PT; Shadforth MF
    Clin Rheumatol; 1994 Sep; 13(3):522-4. PubMed ID: 7835022
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lack of induction of antinuclear antibodies by D-penicillamine in rheumatoid arthritis: a controlled study.
    Weinstein A; Rothfield NF
    J Rheumatol; 1986 Apr; 13(2):308-12. PubMed ID: 3487646
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The heterogeneity of serologic findings and predisposing host factors in drug-induced lupus erythematosus.
    Hughes GR; Rynes RI; Gharavi A; Ryan PF; Sewell J; Mansilla R
    Arthritis Rheum; 1981 Aug; 24(8):1070-3. PubMed ID: 6974553
    [No Abstract]   [Full Text] [Related]  

  • 8. [Lupus biology: incidence and development in 84 rheumatoid polyarthritis patients treated with D-penicillamine].
    Clerc D; Sallière D; Segond P; Bisson M; Massias P
    Ann Med Interne (Paris); 1984; 135(6):420-6. PubMed ID: 6334465
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Penicillamine induced lupus-like syndrome in a patient with classical rheumatoid arthritis.
    Chin GL; Kong NC; Lee BC; Rose IM
    J Rheumatol; 1991 Jun; 18(6):947-8. PubMed ID: 1895285
    [No Abstract]   [Full Text] [Related]  

  • 10. HLA and disease manifestations in rheumatoid arthritis--a Canadian experience.
    Gladman DD; Anhorn KA
    J Rheumatol; 1986 Apr; 13(2):274-6. PubMed ID: 3459890
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systemic lupus erythematosus-like syndrome with focal proliferative glomerulonephritis during D-penicillamine therapy.
    Donnelly S; Levison DA; Doyle DV
    Br J Rheumatol; 1993 Mar; 32(3):251-3. PubMed ID: 8448620
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Penicillamine-induced proteinuria: risk factors.
    Stein HB; Schroeder ML; Dillon AM
    Semin Arthritis Rheum; 1986 May; 15(4):282-7. PubMed ID: 3487119
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HLA system and side effects of gold salts and D-penicillamine treatment of rheumatoid arthritis.
    Bardin T; Dryll A; Debeyre N; Ryckewaert A; Legrand L; Marcelli A; Dausset J
    Ann Rheum Dis; 1982 Dec; 41(6):599-601. PubMed ID: 6959574
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HLA-DR antigens and toxic reaction to sodium aurothiomalate and D-penicillamine in patients with rheumatoid arthritis.
    Wooley PH; Griffin J; Panayi GS; Batchelor JR; Welsh KI; Gibson TJ
    N Engl J Med; 1980 Aug; 303(6):300-2. PubMed ID: 6770269
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiple side effects of penicillamine therapy in one patient with rheumatoid arthritis.
    Essigman WK
    Ann Rheum Dis; 1982 Dec; 41(6):617-20. PubMed ID: 6216862
    [TBL] [Abstract][Full Text] [Related]  

  • 16. D-penicillamine and lupus erythematosuslike syndrome.
    Harkcom TM; Conn DL; Holley KE
    Ann Intern Med; 1978 Dec; 89(6):1012. PubMed ID: 717982
    [No Abstract]   [Full Text] [Related]  

  • 17. C1 inhibitor deficiency in a patient with rheumatoid arthritis--increased risk of adverse effects of penicillamine?
    Sturfelt G; Rydgren L; Truedsson L; Alm P; Sjöholm AG
    J Rheumatol; 1996 Feb; 23(2):378-81. PubMed ID: 8882051
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sequential gold and penicillamine therapy in rheumatoid arthritis.
    Halla JT; Cassady J; Hardin JG
    Am J Med; 1982 Mar; 72(3):423-6. PubMed ID: 6174045
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug-induced autoimmune disease.
    Spears CJ; Batchelor JR
    Adv Nephrol Necker Hosp; 1987; 16():219-29. PubMed ID: 3101425
    [No Abstract]   [Full Text] [Related]  

  • 20. Association of HLA-DRw4 with rheumatoid arthritis in black and white patients.
    Karr RW; Rodey GE; Lee T; Schwartz BD
    Arthritis Rheum; 1980 Nov; 23(11):1241-5. PubMed ID: 6934774
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.